AQST
Aquestive Therapeutics Inc
NASDAQ · Pharmaceuticals
$4.11
+0.27 (+7.03%)
Open$3.91
Previous Close$3.84
Day High$4.18
Day Low$3.88
52W High$7.55
52W Low$2.12
Volume—
Avg Volume9.85M
Market Cap501.43M
P/E Ratio—
EPS$-0.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+530.2% upside
Current
$4.11
$4.11
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 80.97M | 77.69M | 128.24M |
| Net Income | -62,087,381 | -53,610,901 | 31.04M |
| Profit Margin | -76.7% | -72.9% | 24.2% |
| EBITDA | -50,289,680 | -45,836,319 | 59.39M |
| Free Cash Flow | — | — | 29.99M |
| Rev Growth | +4.2% | +4.2% | +19.4% |
| Debt/Equity | 4.68 | 4.68 | 0.42 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |